Document is current
Any future updates will be listed below
-
Authors
Shi, Bingyu
Qi, Jingjing
Yao, Genhong
Feng, Ruihai
Zhang, Zhuoya
Wang, Dandan
Chen, Chen
Tang, Xiaojun
Lu, Liwei
Chen, Wanjun
Sun, Lingyun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81571583)
- License Information
-
More Information
Article History
Received: 3 April 2018
Revised: 1 September 2018
Accepted: 30 September 2018
First Online: 8 November 2018
Ethics approval and consent to participate
: All animal experiments were approved by Ethics Committee of the Affiliated Drum Tower Hospital of Nanjing University Medical School. This study was approved by the Ethics Committee at the Drum Tower Hospital of Nanjing University Medical School and registered at ExternalRef removed. (NTC00953485, Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren’s Syndrome, registered August 6, 2009, first participant enrolled on September 1, 2009). All patients gave consent to participate.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
